Articles

• Search by keyword
• Search by citation

1. Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

   There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolip...

   Authors: Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, Colomba Falcone and Pietro Fratino

   Citation: Cardiovascular Diabetology 2002 1:5

   Content type: Original investigation Published on: 22 November 2002

   • View Full Text
   • View PDF

2. Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects

   The increase in the prevalence of insulin resistance-related metabolic syndrome, a disorder that greatly increases the risk of diabetes, heart attack and stroke, is alarming. One of the most frequent and early...

   Authors: Radka Lichnovská, Simona Gwozdziewiczová and Jirí Hrebícek

   Citation: Cardiovascular Diabetology 2002 1:4

   Content type: Original investigation Published on: 14 October 2002

   • View Full Text
   • View PDF

3. Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy

   Metabolic syndrome, insulin resistance, prediabetes, and overt type 2 diabetes mellitus are associated with an accelerated atherosclerosis (atheroscleropathy). This quartet is also associated with multiple met...

   Authors: Melvin R Hayden and Suresh C Tyagi

   Citation: Cardiovascular Diabetology 2002 1:3

   Content type: Review Published on: 27 September 2002

   • View Full Text
   • View PDF

4. Losartan and diabetic nephropathy: commentaries on the RENAAL study

   The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published. It was aimed ...

   Authors: Enrique Z Fisman, Alexander Tenenbaum and Michael Motro

   Citation: Cardiovascular Diabetology 2002 1:2

   Content type: Commentary Published on: 8 April 2002

   • View Full Text
   • View PDF

5. How hyperglycemia promotes atherosclerosis: molecular mechanisms

   Both type I and type II diabetes are powerful and independent risk factors for coronary artery disease (CAD), stroke, and peripheral arterial disease. Atherosclerosis accounts for virtually 80% of all deaths a...

   Authors: Doron Aronson and Elliot J Rayfield

   Citation: Cardiovascular Diabetology 2002 1:1

   Content type: Review Published on: 8 April 2002

   • View Full Text
   • View PDF